Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP).

Salas, Clara; Martín-López, Javier; Martínez-Pozo, Antonio; Hernández-Iglesias, Teresa; Carcedo, David; Ruiz de Alda, Lucia; García, J Francisco; Rojo, Federico

Salas, Clara; Martín-López, Javier; Martínez-Pozo, Antonio; Hernández-Iglesias, Teresa; Carcedo, David; Ruiz de Alda, Lucia; García, J Francisco; Rojo, Federico.

Affiliation

Salas C; Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Martín-López J; External Quality Asessment (GCP) of the Spanish Society of Pathology (SEAP), Madrid, Spain.
Martínez-Pozo A; Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Hernández-Iglesias T; External Quality Asessment (GCP) of the Spanish Society of Pathology (SEAP), Madrid, Spain.
Carcedo D; Pathology Department, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
Ruiz de Alda L; Quality Control Program, Spanish Society of Pathology (SEAP), Madrid, Spain.
García JF; Hygeia Consulting S.A, Barcelona, Spain david.carcedo@hygeiaconsulting.com.
Rojo F; Roche Farma S.A, Madrid, Spain.

J Clin Pathol ; 75(3): 193-200, 2022 Mar.

Article in En | MEDLINE | ID: mdl-33722840

Subject(s)
Key words

biomarkers; lung neoplasms; statistics; tumour

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Clin Pathol Year: 2022 Document type: Article Affiliation country: España Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google